Detalhe da pesquisa
1.
Metabolic Dysfunction-Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction.
Gastroenterology
; 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513745
2.
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study.
Lancet
; 402(10406): 988-996, 2023 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37572680
3.
Metabolic dysfunction-associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality.
Hepatology
; 77(3): 942-948, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35776631
4.
Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort study.
Hepatology
; 77(2): 585-593, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35753042
5.
Plasma proteomic signature of fatty liver disease: The Rotterdam Study.
Hepatology
; 78(1): 284-294, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36738080
6.
Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B.
Clin Gastroenterol Hepatol
; 21(12): 3089-3096.e1, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37004973
7.
Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study.
Hepatology
; 75(2): 419-429, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34453359
8.
Liver stiffness is associated with excess mortality in the general population driven by heart failure: The Rotterdam Study.
Liver Int
; 43(5): 1000-1007, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36744819
9.
Liver stiffness not fatty liver disease is associated with atrial fibrillation: The Rotterdam study.
J Hepatol
; 77(4): 931-938, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35688226
10.
Objectively Measured Physical Activity Is Inversely Associated With Nonalcoholic Fatty Liver Disease: The Rotterdam Study.
Am J Gastroenterol
; 117(2): 311-318, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34904966
11.
Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta-analysis: Focusing on the non-overlap groups.
Liver Int
; 42(2): 277-287, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953098
12.
LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries.
BMC Public Health
; 22(1): 1385, 2022 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35854275
14.
Reply: Is there survival bias? The etiologic analysis for the negative association between fatty liver and mortality in the elderly populations.
Hepatology
; 78(2): E31-E32, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37162158
19.
Modifiable risk factors for fatty liver disease: Time to act.
Hepatology
; 77(3): 712-714, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36114010
20.
Discrepancy Between NAFLD and MAFLD: Is it Only Due to Misclassification of MAFLD?
Clin Gastroenterol Hepatol
; 21(3): 849, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35483603